Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 14, 2015		Jun. 15, 2014
Cash flows from operating activities:
Net income	$ 92,198		$ 78,936
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,028		13,077
Gains on sale/disposal of assets	(272)		(1,687)
Amortization of deferred financing costs	2,550		2,771
Benefit from deferred income taxes	(1,964)		(2,187)
Non-cash compensation expense	7,776		8,080
Tax impact from equity-based compensation	(7,556)		(8,319)
Other	(725)		(623)
Changes in operating assets and liabilities	(3,441)		(29,258)
Net cash provided by operating activities	103,594		60,790
Cash flows from investing activities:
Capital expenditures	(20,238)		(18,948)
Proceeds from sale of assets	8,785		4,967
Changes in restricted cash	24,137		50,743
Other	1,449		(1,049)
Net cash provided by investing activities	14,133		35,713
Cash flows from financing activities:
Repayments of long-term debt and capital lease obligations	(141)		(12,022)
Proceeds from exercise of stock options	2,067		2,648
Tax impact from equity-based compensation	7,556		8,319
Purchases of common stock	(97,634)		(65,006)
Tax payments for restricted stock upon vesting	(3,737)		(4,363)
Payments of common stock dividends and equivalents	(31,039)		(25,130)
Net cash used in financing activities	(122,928)		(95,554)
Effect of exchange rate changes on cash and cash equivalents	237		(28)
Change in cash and cash equivalents	(4,964)		921
Cash and cash equivalents, at beginning of period	30,855	[1]	14,383
Cash and cash equivalents, at end of period	$ 25,891		$ 15,304

[1] The balance sheet at December 28, 2014 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.